Growth hormone cannot enhance the recovery of dexamethasone-induced osteopenia after withdrawal in young female wistar rats

Tohoku Journal of Experimental Medicine

Volumn 204, Issue 4, 2004, Pages 257-266

  Huang, Tien Shang ^a   Yang, Rong Sen ^a   Tsai, Tsang Wu ^a   Liu, Shin Hwa ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Bone mineral density; Dexamethasone; Growth hormone; Osteocalcin; Osteopenia

Indexed keywords

DEXAMETHASONE; HUMAN GROWTH HORMONE; LIPID; OSTEOCALCIN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTHROPOMETRY; ARTICLE; BODY WEIGHT DISORDER; BONE DENSITY; BONE DISEASE; BONE MARROW; BONE METABOLISM; BONE MINERAL; BONE TURNOVER; CATCH UP GROWTH; CONTROLLED STUDY; DOSE RESPONSE; DRUG WITHDRAWAL; FEMALE; GROWTH PLATE; HISTOPATHOLOGY; MEDICAL ASSESSMENT; MORPHOMETRICS; NONHUMAN; OSTEOPENIA; RAT; THICKNESS; TIBIA; TRABECULAR BONE; TREATMENT FAILURE; TREATMENT OUTCOME; WEIGHT GAIN;

ANIMALS; BONE AND BONES; BONE DENSITY; BONE DISEASES, METABOLIC; DEXAMETHASONE; FEMALE; GROWTH HORMONE; OSTEOCALCIN; PEPTIDE FRAGMENTS; PROCOLLAGEN; RANDOM ALLOCATION; RATS; RATS, WISTAR;

EID: 10244222922     PISSN: 00408727     EISSN: None     Source Type: Journal    
DOI: 10.1620/tjem.204.257     Document Type: Article

References (44)

1. Aaron, J.E., Francis, R.M., Peacock, M. & Makins, N.B. (1989) Contrasting microanatomy of idiopathic and corticosteroid-induced osteoporosis. Clin. Orthop., 243, 294-305.
2. Adachi, J.D. (1997) Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis. New Engl. J. Med., 337, 382-387.
3. Adler, R.A. & Rosen, C.J. (1994) Glucocorticoids and osteoporosis. Endocrinol. Metab. Clin. North Am., 23, 641-654.
4. Andreassen, T.T. & Oxlund, H. (2000) The influence of combined parathyroid hormone and growth hormone treatment on cortical bone in aged ovariectomized rats. J. Bone Miner. Res., 15, 2266-2275.
5. Barnard, R., Ng, K.W., Martin, T.J. & Waters, M.J. (1991) Growth hormone (GH) receptors in clonal osteoblasts-like cells mediate a mitogenic response to GH. Endocrinology, 128, 1459-1464.
6. Bozzola, M., Locatelli, F., Gambarana, D., Moretta, A., Valtorta, A., Giorgiani, G., Cisternino, M. & Severi, F. (1991) Effect of corticoid therapy on growth hormone secretion. Horm. Res., 36 183-186.
7. Brixen, K., Kassem, M., Eriksen, E.F., Nielsen, H.K., Flyvbjerg, A. & Mosekilde, L. (1993) Growth hormone (GH) and adult bone remodeling: the potential use of GH in treatment of osteoporosis. J. Ped. Endocrinol., 16, 65-71.
8. Canalis, E. (1996) Mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis. J. Clin. Endocrinol. Metab., 81, 3441-3447.
9. Chappard, D., Legrand, E., Basle, M.F., Fromont, P., Racineux, J.L., Rebel, A. & Audran, M. (1996) Altered trabecular architecture induced by corticosteroids: a bone histomorphometric study. J. Bone Miner. Res., 11, 676-685.
10. Demiralp, B., Chen, H.L., Koh, A.J., Keller, E.T. & McCauley, L.K. (2002) Anabolic actions of parathyroid hormone during bone growth are dependent on c-fos. Endocrinology, 143, 4038-4047.
11. Dempster, D.W., Arlot, M.A. & Meunier, P.J. (1983) Mean wall thickness and formation periods of trabeculae bone packets in corticosteroid-induced osteoporosis. Calcif. Tissue Int., 35, 410-417.
12. Eriksen, E.F., Kasse, M. & Brixen, K. (1993) Growth hormone and insulin-like growth factor as anabolic therapies for osteoporosis. Horm. Res., 40, 95-98.
13. Feldman, S., Cointry, G.R., Leite Duarte, M.E., Sarrio, L., Ferretti, J.L. & Capozza, R.F. (2004) Effects of hypophysectomy and recombinant human growth hormone on material and geometric properties and the pre- and post-yield behavior of femurs in young rats. Bone, 34, 203-215.
14. Gennari, C. (1994) Glucocorticoid induced osteoporosis. Clin. Endocrinol., 41, 273-274.
15. Hermus, A.R., Huysmans, D.A., Smals, A.G., Corstens, F.H. & Kloppenborg, P.W. (1994) Remarkable improvement of osteopenia after cure of Cushing's syndrome. Horm. Metab. Res., 26, 209-210.
16. Huang, T.S. (1994) Adrenocorticotropin secretagogues facilitate recovery of the hypothalamus-pituitary adrenal axis suppressed by prolonged treatment with dexamethasone. Metabolism, 43, 544-548.
17. Inzucchi, S.E. & Robbins, R.J. (1994) Effects of growth hormone on human bone biology. J. Clin. Endocrinol. Metab., 79 691-694.
18. Kassem, M., Blum, W., Ristelli, J., Mosekilde, L. & Eriksen, E.F. (1993) Growth hormone stimulates proliferation and differentiation of normal human osteoblasts-like cells in vitro. Calcif. Tissue Int. 52, 222-226.
19. Leong, G.M., Mercado-Asis, L.B., Reynolds, J.C., Hill, S.C., Oldfield, E.H. & Chrousos, G.P. (1996) The effect of Cushing's disease on bone mineral density, body composition, growth and puberty: a report of an identical adolescent twin pair. J. Clin. Endocrinol. Metab., 81, 1905-1911.
20. Lufkin, E.G., Wahner, H.W. & Bergstralh, E.J. (1988) Reversibility of steroid-induced osteoporosis. Am. J. Med., 85 887-888.
21. Lukert, B.P., Johnson, B.E. & Robinson, R.G. (1992) Estrogen and progesterone replacement therapy reduces glucocorticoid-induced osteoporosis. J. Bone Miner. Res., 7, 1063-1069.
22. Lukert, B.P. & Raisz, L.G. (1990) Glucocorticoid-induced osteoporosis: Pathogenesis and management. Ann. Intern. Med., 112, 352-364.
23. Mauras, N. (2001) Growth hormone therapy in the glucocorticosteroid-dependent child: metabolic and linear growth effects. Horm. Res., 56, Suppl. 1, 13-18.
24. Mauras, N., George, D., Evans, J., Milov, D., Abrams, S., Rini, A., Welch, S. & Haymond, M.W. (2002) Growth hormone has anabolic effects in glucocorticosteroid-dependent children with inflammatory bowel disease: a pilot study. Metabolism, 51, 127-135.
25. McCarthy, T.L., Centrella, M. & Canalis, E. (1990) Cortisol inhibits the synthesis of insulin-like growth factor-1 in skeletal cells. Endocrinology, 126, 1569-1575.
26. Miell, J.P., Corder, R., Pralong, F.P. & Gaillard, R.C. (1991) Effects of dexamethasone on growth hormone (GH) releasing hormone, arginine-and dopaminergic stimulated GH secretion and total plasma insulin-like growth factor-1 concentration in normal male volunteers. J Clin. Endocrinol. Metab., 72, 675-681.
27. Montemurro, L., Schiraldi, G., Fraioli, P., Tosi, G., Riboldl, Q. & Rizzato, G. (1991) Prevention of corticosteroid-induced osteoporosis with salmon calcitonin in sarcoid patients. Calcif. Tissue Int., 49, 71-76.
28. Nilsson, A., Isgaard, J., Lindahl, A., Dahlstrom, A., Skottner, A. & Isaksson, O.G. (1986) Regulation by growth hormone of number of chondrocytes containing IGF-I in rat growth plate. Science 233, 571-574.
29. Ørtoft, G., Andreassen, T.T. & Oxlund, H. (1999) Growth hormone increases cortical and cancellous bone mass in young growing rats with glucocorticoid-induced osteopenia. J. Bone Miner. Res., 14 710-721.
30. Peretz, A., Praet, J.P., Bosson, D., Rozenberg, S. & Bourdoux, P. (1989) Serum osteocalcin in the assessment of corticosteroid induced osteoporosis. Effect of long and short term corticosteroid treatment. J. Rheumatol., 16, 363-367.
31. Pocock, N.A., Eisman, J.A., Dunstan, C.R., Evans, R.A., Thomas, D.H. & Laila, H.N. (1987) Recovery from steroid-induced osteoporosis. Ann. Intern. Med., 107, 319-323.
32. Prummel, M.F., Wiersinga, W.M., Lips, P., Sanders, G.T.B. & Sauerwien, H.P. (1991) The course of biochemical parameters of bone turnover during treatment with corticosteroids. J. Clin. Endocrinol. Metab., 72, 382-386.
33. Rappaport, E.B., Snoy, P., Habig, W.H. & Bright, R.W. (1987) Effects of exogenous growth hormone on growth plate cartilage in rats. Am. J. Dis. Child, 141, 497-501.
34. Reid, I.R. (1997) Glococorticoid osteoporosis: Mechanisms and management. Eur J. Endocrinol., 137, 209-217.
35. Reinecke, M., Schmid, A.C., Heyberger-Meyer, B., Hunziker, E.B. & Zapf, J. (2000) Effect of growth hormone and insulin-like growth factor I (IGF-I) on the expression of IGF-I messenger ribonucleic acid and peptide in rat tibial growth plate and articular chondrocytes in vivo. Endocrinology, 141, 2847-2853.
36. Rydziel, S. & Canalis, E. (1995) Cortisol represses insulin-like growth factor-1 receptor transcription in skeletal cell cultures. Endocrinology, 136, 4254-4260.
37. Saggese, G., Federico, G. & Cinquanta, L. (1993) In vitro effects of growth hormone and other hormones on chondrocytes and osteoblasts-like cells. Acta Paediatr. Suppl., 391, 54-59.
38. Sambrook, P.N., Kotowicz, M., Nash, P., Styles, C.B., Naganathan, V., Henderson-Briffa, K.N., Eisman, J.A., & Nicholson, G.C. (2003) Prevention and treatment of glucocorticoid-induced osteoporosis: a comparison of calcitriol, vitamin D plus calcium, and alendronate plus calcium. J. Bone Miner. Res., 18, 919-924.
39. Slootweg, M.C. (1993) Growth Hormone and bone. Horm. Metab. Res., 25, 335-343.
40. Trippel, S.B., Corvol, M.T., Dumontier, M.F., Rappaport, R., Hung, H.H. & Mankin, H.J. (1989) Effect of somatomedin-C/insulin-like growth factor I and growth hormone on cultured growth plate and articular chondrocytes. Pediatr Res., 25, 76-82.
41. Vandeweghe, M., Taelman, P. & Kaufman, J.M. (1993) Short- and long-term effects of growth hormone treatment on bone turnover and bone mineral content in adult growth hormone-deficient males. Clin. Endocrinol., 39, 409-415.
42. Ward, W.E., Donovan, S.M. & Atkinson, S.A. (1998) Dexamethasone-induced abnormalities in growth and bone metabolism in piglets are partially attenuated by growth hormone with no synergistic effect of insulin-like growth factor-I. Pediatr Res., 44, 215-221.
43. Watts, N.B. (2003) Bisphosphonates treatment of osteoporosis. Clin. Geriatr. Med., 19, 395-414.
44. Yang, R.S., Liu, T.K. & Lin-Shiau, S.Y. (1993) Increased bone growth by local prostaglandin E2 in rats. Calcif. Tissue Int., 52, 57-61.